Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05621538

A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder

Conditions: Alcohol Use Disorder

Sex: All
Ages: 19 Years – 65 Years
Phase: NA
Enrollment: 90
Sponsor: Auburn University

Location: United States

Summary

The goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder.After an initial visit, participants will come in once a week for four (4) weeks for an intervention session, which may or may not include TMS and MRI. Participants will be contacted for monthly follow-ups (remotely) for up to 12 months and will be asked to come in for two MRI follow-ups at 6 and 12 months.

Eligibility Criteria

Inclusion Criteria:Age 19-65Receiving treatment for Alcohol Use DisorderExclusion Criteria:MRI ContraindicationsPresence of metal in the body that would make having a 7T MRI unsafe (including facial tattoos)Claustrophobia, such that individual would be unable to stay in the MRI for up to 1 hrHearing loss, including tinnitus, that might be made worse by MRI or TMSTMS ContraindicationsHas ever had a seizure, or has a family history of epilepsyTaking medications or substances that lower the seizure thresholdImplanted devices that are in the head or rely on physiological signalsHistory of neurological disease, such as stroke or brain tumorHead injury with loss of consciousness greater than 30 minutesActively withdrawing from alcoholFamily history of schizophrenia or presence of psychotic symptoms

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05621538). StuddyBuddy aggregates publicly available trial information.